|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Insulin IRMA Assay | Anti-Ustekinumab (Stelara®) ELISA | Complement System Alternative Pathway ELISA Assay | Helicobacter pylori IgG ELISA Assay | Thioredoxin ELISA Assay |
| Citations | | | | | |
| Catalog Number | KIP1251 | TM09036 | COMPL AP330 RUO | IB05065 | 27417 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Immunoradiometric assay (RIA) for the quantitative determination of human Insulin (INS) in serum. FDA exempt, can be used for in-vitro diagnostics. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Wieslab® COMPL AP330 kit is an enzyme immunoassay (ELISA) for the determination of functional alternative complement pathway in human serum. For research use only, not for use in diagnostic procedures. | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgG antibodies in serum or plasma directed against Helicobacter pylori. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Thioredoxin in serum, EDTA plasma, urine and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Leptin | sAPP Total | Human Osteocalcin (OC/BGP) | Measles Virus IgG | Anti-Certolizumab pegol (Cimzia®) |
| Sample Type | Serum, Blood Plasma, Urine, Saliva | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, plasma, tissue homogenates and other biological fluids. | Serum, Blood Plasma | Serum and plasma. |
| Method | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 5.7 to 440 µIU/mL | Anti-Ustekinumab (Stelara®) | Inquire | Inquire | 3.91 to 250 ng/mL |
| Sensitivity | 1.0 ng/mL | 0.06 ng/mL | 0.75 ng/mL | 97.01% (95% confidence interval: 93.93% - 98.79%) | 40 ng/mL |
| Assay Time | 2 hrs (incubation) | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) | 2 hrs (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |